CA2212430A1 — Inhalation device
Assigned to Individual · Expires 1999-02-07 · 27y expired
What this patent protects
An inhalation device for use in delivering a powdered medicament to a user, the inhalation device comprises a housing including a portion for holding the medicament; an air entry passageway sized and configured to direct air entering the inhalation device at the portion and to fl…
USPTO Abstract
An inhalation device for use in delivering a powdered medicament to a user, the inhalation device comprises a housing including a portion for holding the medicament; an air entry passageway sized and configured to direct air entering the inhalation device at the portion and to fluidize the medicament upon inhalation by the user; a hold up chamber in flow communication with the portion for receiving the fluidized medicament and maintaining the medicament in a fluidized state during inhalation by the user; and, an air exit passageway in flow communication with the hold up chamber and adapted to deliver the medicament to the mouth or nose of a user.
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.